P36.0
BillableSepsis of newborn due to streptococcus, group B
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is P36.0 an HCC code?
Yes. P36.0 maps to Septicemia, Sepsis, Systemic Inflammatory Response Syndrome/Shock under the CMS-HCC V28 risk adjustment model (and Septicemia, Sepsis, Systemic Inflammatory Response Syndrome/Shock under V24).
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for P36.0
For P36.0 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed P36.0 during that encounter — not just copy-forwarded from a problem list.
What This Code Means
P36.0 is the ICD-10-CM diagnosis code for sepsis of newborn due to streptococcus, group b. A serious bloodstream infection (sepsis) in a newborn caused by Group B Streptococcus bacteria, typically acquired from the mother during delivery. P36.0 sits in the ICD-10-CM chapter for certain conditions originating in the perinatal period (p00-p96), within the section covering infections specific to the perinatal period (p35-p39).
Under the CMS-HCC V28 risk adjustment model, P36.0 maps to Septicemia, Sepsis, Systemic Inflammatory Response Syndrome/Shock (HCC 2) with a community, non-dual, aged base RAF weight of 0.455. The V24 model used during the PY2024–PY2025 transition mapped P36.0 the same way and at the same RAF weight. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Document the clinical presentation (early-onset vs. late-onset) as this affects treatment protocols. Because P36.0 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for P36.0 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Document the clinical presentation (early-onset vs. late-onset) as this affects treatment protocols
- •Verify maternal Group B Streptococcus colonization status is documented in the medical record
Clinical Significance
Group B Streptococcus (GBS) sepsis in newborns is a serious bacterial infection with high morbidity and mortality risk, often acquired during delivery from maternal GBS colonization. Early recognition and aggressive antibiotic treatment are critical to prevent complications such as meningitis, pneumonia, and septic shock that can result in long-term neurodevelopmental sequelae.
Documentation Requirements
- ✓Positive culture or antigen test for Group B Streptococcus
- ✓Clinical signs of sepsis or systemic infection
- ✓Gestational age and birth weight
- ✓Maternal GBS status if known
- ✓Blood culture results
- ✓Antibiotic treatment initiated
- ✓Laboratory values supporting sepsis (CBC, inflammatory markers)
- ✓Clinical response to treatment